Search results

Records found: 7  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth 0004462 xcla^"
  1. A novel quasi-viral agent, MaTu, is a two-component system  / S. Pastoreková ... [et al.] .  Virology . - Vol. 187, no. 2 (1992), s. 620-626   [Dokument nie je vo fonde knižnice]
    article

    article

  2. Expresion of Ma Tu-MN protein in human tumor cultures and in clinical specimens  / J. Závada ... [et al.] .  Int. J. Cancer . - Vol. 54 (1993), s. 268-274   [Dokument nie je vo fonde knižnice]
    article

    article

  3. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens  / Závada, J. ... [et al.] .  International journal of cancer . - Vol. 54, no. 2 (1993), s. 268-274   [Dokument nie je vo fonde knižnice]
    article

    article

  4. Human tumour-associated cell adhesion protein MN/CA IX : identification of M75 epitope and of the region mediating cell adhesion  / J. Závada ... [et al.] .  British journal of cancer . - Vol. 82, no. 11 (2000), s. 1808-1813   [Dokument nie je vo fonde knižnice]
    article

    article

  5. Identification of MaTu-MX agent as a new strain of lymphocytic choriomeningitis virus (LCMV) and serological indication of horizontal spread of LCMV in human population  / L. Reiserová ... [et al.] .  Virology . - Vol. 257, no. 1, (1999), s. 73-83   [Dokument nie je vo fonde knižnice]
    article

    article

  6. Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients  / Zavada J., Zavadova Z., Zatovicova M. ... et al. .  British journal of cancer . - Vol. 89, issue 6 (2003), pp. 1067-1071   [Dokument nie je vo fonde knižnice]
    article

    article

  7. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract  / L. Hyrsl ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 56, no. 4 (2009), s. 298-302  : ilustr., grafy, obr., tab.  
    C 720
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.